Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 45,144 | 227,552 | 188,893 | 90,592 | 235,358 |
| Marketable Securities | 380,851 | 257,089 | 150,384 | 113,007 | 0 |
| Receivables | N/A | N/A | N/A | 163 | 1,646 |
| TOTAL | $435,736 | $487,273 | $341,528 | $205,949 | $239,886 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 331 | 329 | 331 | 1,316 | 3,643 |
| TOTAL | $331 | $329 | $331 | $1,316 | $3,643 |
| Total Assets | $436,067 | $487,602 | $341,859 | $207,265 | $243,529 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,799 | 18,634 | 17,480 | 21,501 | 23,664 |
| Accrued Expenses | 5,683 | 21,594 | 13,108 | 15,861 | 28,427 |
| Other current liabilities | 2,640 | 2,590 | 1,390 | 7,510 | 174,882 |
| TOTAL | $22,122 | $42,818 | $31,978 | $44,872 | $232,234 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 930 |
| Other Non-Current Liabilities | 39,560 | 292,515 | 125,865 | 407,795 | 216,323 |
| TOTAL | $39,560 | $292,515 | $125,865 | $407,795 | $218,664 |
| Total Liabilities | $61,682 | $335,333 | $157,843 | $452,667 | $450,898 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,792 | 40,283 | 36,151 | 4,049 | 4,048 |
| Common Shares | 12 | 10 | 10 | 7 | 6 |
| Retained earnings | -847,108 | -808,271 | -764,414 | -701,234 | -661,127 |
| Other shareholders' equity | 155,267 | 184,564 | 185,229 | -132 | 11 |
| TOTAL | $374,385 | $152,269 | $184,016 | $-245,402 | $-207,369 |
| Total Liabilities And Equity | $436,067 | $487,602 | $341,859 | $207,265 | $243,529 |